Burden of Mild (<13 g/dl) Anemia in Patients With Atrial Fibrillation (A Report from a Multicenter Registry With Patient-Reported Outcomes).

[1]  M. Hlatky,et al.  Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study. , 2019, European heart journal.

[2]  J. Piccini,et al.  Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation—Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF) , 2019, BMJ Open.

[3]  K. Okumura,et al.  Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: A subanalysis of the J-RHYTHM Registry. , 2019, International journal of cardiology.

[4]  Young-Ju Kim,et al.  Anemia and health-related quality of life in South Korea: data from the Korean national health and nutrition examination survey 2008–2016 , 2019, BMC Public Health.

[5]  Y. Huang,et al.  Safety and Effectiveness of Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study , 2019, Journal of the American Heart Association.

[6]  K. Anstrom,et al.  Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[7]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[8]  H. Miyata,et al.  Relation of Baseline Hemoglobin Level to In-Hospital Outcomes in Patients Who Undergo Percutaneous Coronary Intervention (from a Japanese Multicenter Registry). , 2017, American Journal of Cardiology.

[9]  B. Gersh,et al.  No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction. , 2017, Heart rhythm.

[10]  R. de Caterina,et al.  Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial , 2017, American heart journal.

[11]  Sally Hopewell,et al.  Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis , 2016, British Medical Journal.

[12]  D. Levy,et al.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. , 2016, Circulation.

[13]  N. Sato,et al.  Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes , 2015, European heart journal. Acute cardiovascular care.

[14]  S. Schulman,et al.  Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH , 2015, Journal of thrombosis and haemostasis : JTH.

[15]  Emily C. O'Brien,et al.  The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation , 2015, European heart journal.

[16]  S. Yusuf,et al.  Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial , 2015, Journal of thrombosis and haemostasis : JTH.

[17]  E. Benjamin,et al.  Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. , 2014, European heart journal.

[18]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[19]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[20]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[21]  D. Singer,et al.  A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. , 2011, Journal of the American College of Cardiology.

[22]  John Spertus,et al.  Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[23]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[24]  M. Rich,et al.  Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation. , 2009, American heart journal.

[25]  H. Hillege,et al.  Anemia and mortality in heart failure patients a systematic review and meta-analysis. , 2008, Journal of the American College of Cardiology.

[26]  M. Rich,et al.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). , 2006, American heart journal.

[27]  L. Ferrucci,et al.  Anemia Is Associated with Disability and Decreased Physical Performance and Muscle Strength in the Elderly , 2004, Journal of the American Geriatrics Society.

[28]  E. Beutner,et al.  Report of a WHO Scientific Group (Part 3 of 3) , 1973 .